Virtonomy.io Information

Virtonomy is a Munich-based MedTech company helping cardiovascular medical device manufacturers accelerate development, identify risks earlier, and build evidence of safety and performance through digital patient twins and in silico simulations. Its browser-based v-Patients platform supports R&D, engineering, clinical, and regulatory teams — from early design decisions to regulatory evidence preparation. Applications include heart valves, stents, catheters, cannulas, occluders, ventricular assist devices, and total artificial hearts, and other cardiovascular devices. A growing database of more than 2,500 digital patient twins derived from clinical imaging data represents diverse anatomies, age groups, sexes, pathologies, and geographic regions. Teams can select virtual cohorts, analyze anatomy, implant device designs virtually, and simulate device–anatomy interactions and blood flow in one cloud-based environment. These investigations help teams assess anatomical fit, refine designs, and prepare clinical studies. They complement physical testing and clinical research, supporting shorter development iterations and better-informed decisions. Virtonomy aligns its modeling, validation, and reporting with established frameworks for the credibility of computational evidence. Its technology for automatically assessing medical device fit in virtual patients is protected by granted patents in the US and Europe. Founded in 2019 by Dr. Simon J. Sonntag and Wen-Yang Chu, Virtonomy serves more than 30 customers across Europe, the US, Asia, and Australia, including leading global cardiovascular device manufacturers. Its recognitions include Health Tech Startup of the Year at Med-Tech World and the Innovator of Tomorrow award at Weltmarktführer Innovation Day.